Alunbrig brigatinib

Fact of Medicine

  • Brand Name: Alunbrig
  • Innovator Brand Name: Alunbrig
  • API: Brigatinib
  • Packaging: 21 & 180 Tablets
  • Strength: 30mg
  • Manufacturer Name: Takeda Pharmaceutical
Get Price

Description

Uses of medication: Alunbrig (Brigatinib) is a kinase inhibitor used for the treatment of patients with ALK +Ve metastatic NSCLC (Non Small Cell Lung Cancer) who have progressed on or are intolerant to crizotinib.

Dosage: The recommended brigatinib dose is 90 mg orally, which should be taken either with or without food once daily for the initial 7 days. In case 90 mg is tolerated during the initial 7 days, increase the dose to 180 mg orally once daily. Pills should be swallowed whole. Do not crush/chew brigatinib tablets.

Treatment Reactions: The most commonly reported alunbrig side effects include:

  • Nausea
  • Diarrhea
  • Fatigue
  • Cough
  • Headache

Warnings and Precautions:

  • The safety as well as efficacy of brigatinib uses in the pediatric patients have not been established.
  • Patients taking treatment with brigatinib 30 mg should be monitored for the blood pressure following 2 weeks and then at least monthly during treatment.
  • Patients with brigatinib 180 mg should be monitored for heart rate regularly during treatment.
  • Women with childbearing potential should avoid conceiving a baby while on the brigatinib treatment.
  • Lactating women should avoid breastfeeding during treatment with brigatinib 180 mg and for 1 week after the final dose.

More Info.

Storage: Alunbrig (Brigatinib) should be stored at controlled room temperature 20°C to 25°C (68°F to 77°F); excursion permitted between temperature 15°C to 30°C (59°F to 86°F) away from the heat, moisture, and direct light. Keep this medication in its original container.


Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship ALUNBRIG at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the ALUNBRIG Tablets.


Buying Procedure: In order to buy ALUNBRIG, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp number +919650877511 or an Email to us at: info@theindianpharma.com along with your ID Proof, Valid Prescription Letter and Medical Reports.


Conclusion: Brigatinib, a next-generation ALK inhibitor, demonstrated superior PFS (Progression Free Survival) and improved health associated quality of life (QoL) in the advanced ALK +Ve non-Small Cell Lung Cancer (NSCLC).

Commonly Asked Questions

What does Alunbrig contain as an active substance?


The medication Alunbrig specifically contains the active substance Brigatinib.


From which class of drug Brigatinib belongs?


Brigatinib basically belongs to a class of drugs named kinase inhibitors.


How does Brigatinib act?


Brigatinib specifically acts as an anaplastic lymphoma kinase (ALK) as well as epidermal growth factor receptor (EGFR) inhibitor.


How much does alunbrig cost?


The alunbrig price in India may vary depending on the wholesaler/pharmacy you visit. Cost for alunbrig 90 mg is around 2,99,232 INR for a supply of 7 tablets.


Where can I get Brigatinib at the best price?


In order to get the best brigatinib price, always buy this medication from such Pharmaceutical Wholesaler Company which is WHO-GDP and ISO certified.


Can I get Brigatinib (Alunbrig) even if I am not based in India?


The Indian Pharma helps patients in accessing or importing Brigatinib (Alunbrig), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.


Send your inquiry to find Alunbrig (Brigatinib) Capsules in UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia, Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.